Loxo Oncology, Inc.
Overview
Loxo Oncology, Inc. is a subsidiary of Eli Lilly and Company, specializing in the development of highly selective medicines for patients with genetically defined cancers. The company's mission is to create and deliver breakthrough treatments for cancer patients with significant unmet medical needs.
Therapeutic areas
OncologyCancer Genetics
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Loxo Oncology, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Related companies
Cancer Research Organization
United Kingdom
3D Imaging Drug Design and Development LLC
United States
3t Biosciences
United States
454 Life Sciences Corporation
United States
A&B Pharmaceuticals
United States
Abbvie Inc.
United States
ABC Biopharmaceuticals, Inc.
United States
ABC Cancer Research Institute
United States
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.